The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy
NCT ID: NCT02785679
Last Updated: 2021-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
2500 participants
INTERVENTIONAL
2018-03-20
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
NCT02379598
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
NCT02397876
Early Oral Immunotherapy in Infants With Cow's Milk Protein Allergy
NCT03586388
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541
Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
NCT04651829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exclusive breast feeding
Exclusive breast feeding
No interventions assigned to this group
Exclusive CMF feeding
Exclusive CMF feeding
No interventions assigned to this group
Breast feeding with small amount of CMF
Breast feeding with addition (as intervention) of 20 cc of cow's milk formula (CMF) per day
cow's milk formula
addition of cow's milk formula in two different dosage - one only 20ml per day and one group a full meal per day
Breast feeding with one meal of CMF
Breast feeding with addition (as intervention) of one meal per day of cow's milk formula (CMF)
cow's milk formula
addition of cow's milk formula in two different dosage - one only 20ml per day and one group a full meal per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cow's milk formula
addition of cow's milk formula in two different dosage - one only 20ml per day and one group a full meal per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal birth weight
Exclusion Criteria
* Preterm newborns
* Congenital defects
* Newborn suffering from acute event
2 Hours
2 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schneider Children's Hospital
OTHER
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronit Confino- Cohen, MD
Role: STUDY_DIRECTOR
allergy and immunology unit, MeirMc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir medical center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Lachover-Roth I, Cohen-Engler A, Furman Y, Rosman Y, Meir-Shafrir K, Mozer-Mandel M, Farladansky-Gershnabel S, Biron-Shental T, Confino-Cohen R. Infants born during COVID-19 pandemic experience increased susceptibility to airway hyperresponsiveness. Front Allergy. 2024 Dec 16;5:1512182. doi: 10.3389/falgy.2024.1512182. eCollection 2024.
Lachover-Roth I, Cohen-Engler A, Furman Y, Rosman Y, Meir-Shafrir K, Mozer-Mandel M, Farladansky-Gershnabel S, Biron-Shental T, Confino-Cohen R. Food allergy and infant feeding practices: Are they related? Ann Allergy Asthma Immunol. 2023 Sep;131(3):369-375.e3. doi: 10.1016/j.anai.2023.05.031. Epub 2023 Jun 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
011-16-MMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.